OnCo
ideasIdea

An independent replication institute that re-tests key preclinical cancer findings before trials

Many cancer lab results cannot be reproduced, and trials built on them fail. Fund an independent institute that re-runs important experiments before anyone spends millions on humans.

The Reproducibility Project: Cancer Biology found that most high-profile preclinical results replicated only partially or not at all. Trials and companies are built on unreplicated findings. The proposal is a funded, independent replication institute with standing capacity in the common cancer model systems, which re-tests findings prioritised by their influence on planned trials or investments, publishes all results, and issues a replication grade that funders, investors and ethics committees can require before first-in-human studies.

Hypothesis
Replication grading before phase 1 reduces the rate of early trials terminated for lack of efficacy and shifts investment toward findings that replicate.
Rationale
Independent replication is the cheapest insurance against the most expensive failures; it is not done because nobody owns it and careers do not reward it.
What would test it
Grade 50 findings underlying planned trials; follow the trials for three years and compare outcomes of high- and low-grade findings.
Maturity
early clinical
Who has to act
philanthropy
Cost to try
Medium ($1M to $50M)
Years to first evidence
3
Bottlenecks it attacks

Connected

4top

Pages like this

not linked directly; found by shared links